Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)

Status:
Recruiting

Trial end date:
2024-01-01

Target enrollment:

Participant gender:

The objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in patients with Diabetic Macular Edema.

Phase 2

Rezolute